| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | FZ56898FLE |
Structure
| InChI Key | LXBIFEVIBLOUGU-JGWLITMVSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C6H13NO4 |
| Molecular Weight | 163.17 |
| AlogP | -2.97 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 5.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 92.95 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 11.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 130-25000 | - | 14-23000 | 100 | |
|
Enzyme
|
- | 160-650 | - | 14-23000 | 100 | |
|
Unclassified protein
|
- | 39500 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Glycogen Storage Disease Type II | Phase 2 | ClinicalTrials |
| Glycogen Storage Disease Type II | Phase 2 | ClinicalTrials |
Related Entries
MCS
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 19130-96-2 |
| ChEBI | 44369 |
| ChEMBL | CHEMBL307429 |
| DrugBank | DB03206 |
| EPA CompTox | DTXSID70172647 |
| FDA SRS | FZ56898FLE |
| Guide to Pharmacology | 4642 |
| KEGG | C16843 |
| PDB | NOJ |
| PubChem | 29435 |
| SureChEMBL | SCHEMBL2969 |
| ZINC | ZINC000003794714 |
CONTENTS